Neuraltus Pharmaceuticals, Inc.
Records under this name other than patents Neuraltus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Neuraltus Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,231,856 | Chlorite Formulations and Methods of Preparation and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,266,734 | Chlorite Formulations and Methods of Preparation and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,839,650 | Chlorite Formulations, and Methods of Preparation and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,501,244 | Chlorite Formulations and Methods of Preparation and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,579,346 | Treatment of Macrophage-Related Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,653,686 | Compositions and methods for treatment of symptoms in parkinson's disease patients Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,029,734 | Compositions and methods for treatment of symptoms in Parkinson's disease patients Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,938,147 | Treatment of Neurodegenerative Disease with Sodium Chlorite Formerly held In force · High confidence | In force | High confidence | |
| US 8,252,789 | Compositions and methods for treating lysosomal disorders Lapsed on the fee record Ended Aug 28, 2020 · USPTO record | Lapsed on the fee record | Ended Aug 28, 2020 | USPTO record |
| US 8,067,035 | Chlorite formulations, and methods of preparation and use thereof Formerly held Lapsed on the fee record Ended Nov 29, 2019 · USPTO record | Lapsed on the fee record | Ended Nov 29, 2019 | USPTO record |